Daito Chemix Corporation
Daito Chemix Corporation (4366.T) Financial Performance & Income Statement Overview
Explore the financials of Daito Chemix Corporation (4366.T), including yearly and quarterly data on income, cash flow, and balance sheets.
Daito Chemix Corporation (4366.T) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Daito Chemix Corporation 4366.T financial performance.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $4.54B | $4.80B | $4.75B | $4.55B |
| Cost of Revenue | $4.04B | $4.22B | $4.23B | $4.07B |
| Gross Profit | $501.00M | $581.00M | $511.00M | $480.00M |
| Gross Profit Ratio | $0.11 | $0.12 | $0.11 | $0.11 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $323.00M | $292.00M | $311.00M | $299.00M |
| Operating Expenses | $323.00M | $292.00M | $311.00M | $301.00M |
| Total Costs & Expenses | $4.37B | $4.51B | $4.54B | $4.37B |
| Interest Income | $0.00 | $0.00 | $0.00 | $10.00M |
| Interest Expense | $13.00M | $0.00 | $10.00M | $0.00 |
| Depreciation & Amortization | $387.00M | $370.25M | $1.00M | $370.25M |
| EBITDA | $584.00M | $659.25M | $201.00M | $551.25M |
| EBITDA Ratio | $0.13 | $0.14 | $0.04 | $0.12 |
| Operating Income | $178.00M | $289.00M | $200.00M | $179.00M |
| Operating Income Ratio | $0.04 | $0.06 | $0.04 | $0.04 |
| Other Income/Expenses (Net) | $7.00M | $26.00M | $7.00M | -$34.00M |
| Income Before Tax | $185.00M | $315.00M | $207.00M | $145.00M |
| Income Before Tax Ratio | $0.04 | $0.07 | $0.04 | $0.03 |
| Income Tax Expense | -$188.00M | $86.00M | $64.00M | $71.00M |
| Net Income | $373.00M | $229.00M | $144.00M | $74.00M |
| Net Income Ratio | $0.08 | $0.05 | $0.03 | $0.02 |
| EPS | $34.74 | $21.33 | $13.41 | $6.89 |
| Diluted EPS | $34.74 | $21.33 | $13.41 | $6.89 |
| Weighted Avg Shares Outstanding | $10.74M | $10.74M | $10.74M | $10.74M |
| Weighted Avg Shares Outstanding (Diluted) | $10.74M | $10.74M | $10.74M | $10.74M |
Financial performance has remained strong, with revenue growing from $4.55B in Q1 2024 to $4.54B in Q4 2024. Gross profit continued to perform well, with margins at 11% in the latest quarter. Operating income reached $178.00M in Q4 2024, holding a steady 4% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $584.00M. Net income rose to $373.00M, keeping EPS at $34.74. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan